Literature DB >> 32183766

Metabolic syndrome in indigenous communities in Mexico: a descriptive and cross-sectional study.

Elvia Cristina Mendoza-Caamal1, Francisco Barajas-Olmos2, Humberto García-Ortiz2, Isabel Cicerón-Arellano1, Angélica Martínez-Hernández2, Emilio J Córdova2, Marcelino Esparza-Aguilar3, Cecilia Contreras-Cubas2, Federico Centeno-Cruz2, Miguel Cid-Soto2, Mirna Edith Morales-Marín2, Adriana Reséndiz-Rodríguez1, Juan Luis Jiménez-Ruiz2, María Guadalupe Salas-Martínez2, Yolanda Saldaña-Alvarez2, Elaheh Mirzaeicheshmeh2, María Rosalba Rojas-Martínez4, Lorena Orozco5.   

Abstract

BACKGROUND: An Amerindian genetic background could play an important role in susceptibility to metabolic diseases, which have alarmingly increased in recent decades. Mexico has one of the highest prevalences of metabolic disease worldwide. The purpose of this study was to determine the prevalence of metabolic syndrome and its components in a population with high Amerindian ancestry.
METHODS: We performed a descriptive, quantitative, and analytical cross-sectional study of 2596 adult indigenous volunteers from 60 different ethnic groups. Metabolic syndrome and its components were evaluated using the American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement criteria.
RESULTS: The overall prevalence of metabolic syndrome in the indigenous Mexican population was 50.3%. Although females had a higher prevalence than males (55.6% vs. 38.2%), the males presented with combinations of metabolic syndrome components that confer a higher risk of cardiovascular disease. The most frequent metabolic syndrome component in both genders was low HDL-cholesterol levels (75.8%). Central obesity was the second most frequent component in females (61%), though it had a low prevalence in males (16.5%). The overall prevalence of elevated blood pressure was 42.7% and was higher in males than females (48.8 vs. 40%). We found no gender differences in the overall prevalence of elevated triglycerides (56.7%) or fasting glucose (27.9%).
CONCLUSIONS: We documented that individuals with Amerindian ancestry have a high prevalence of metabolic syndrome. Health policies are needed to control the development of metabolic disorders in a population with high genetic risk.

Entities:  

Keywords:  Blood pressure; Fasting glucose; HDL-cholesterol; Indigenous; Metabolic syndrome; Mexican Amerindian; Prevalence; Triglyceride; Waist circumference

Year:  2020        PMID: 32183766     DOI: 10.1186/s12889-020-8378-5

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  8 in total

1.  Gualou Xiebai Banxia decoction ameliorates Poloxamer 407-induced hyperlipidemia.

Authors:  Mingzhu Luo; Rong Fan; Xiaoming Wang; Junyu Lu; Ping Li; Wenbin Chu; Yonghe Hu; Xuewei Chen
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.976

2.  The Variant rs1784042 of the SIDT2 Gene is Associated with Metabolic Syndrome through Low HDL-c Levels in a Mexican Population.

Authors:  Guadalupe León-Reyes; Berenice Rivera-Paredez; Juan Carlos Fernandez López; Eric G Ramírez-Salazar; Arnoldo Aquino-Gálvez; Katia Gallegos-Carrillo; Edgar Denova-Gutiérrez; Jorge Salmerón; Rafael Velázquez-Cruz
Journal:  Genes (Basel)       Date:  2020-10-14       Impact factor: 4.096

3.  Sex-based differences in and risk factors for metabolic syndrome in adults aged 40 years and above in Northeast China: Results from the cross-sectional China national stroke screening survey.

Authors:  Feng-E Li; Fu-Liang Zhang; Peng Zhang; Dong Liu; Hao-Yuan Liu; Zhen-Ni Guo; Yi Yang
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692

4.  The genomic landscape of Mexican Indigenous populations brings insights into the peopling of the Americas.

Authors:  Humberto García-Ortiz; Francisco Barajas-Olmos; Cecilia Contreras-Cubas; Miguel Ángel Cid-Soto; Emilio J Córdova; Federico Centeno-Cruz; Elvia Mendoza-Caamal; Isabel Cicerón-Arellano; Marlen Flores-Huacuja; Paulina Baca; Deborah A Bolnick; Meradeth Snow; Silvia Esperanza Flores-Martínez; Rocio Ortiz-Lopez; Austin W Reynolds; Antonio Blanchet; Mirna Morales-Marín; Rafael Velázquez-Cruz; Aleksandar David Kostic; Carlos Galaviz-Hernández; Alejandra Guadalupe García-Zapién; José Concepción Jiménez-López; Guadalupe León-Reyes; Eva Gabriela Salas-Bautista; Blanca Patricia Lazalde-Ramos; Juan Luis Jiménez-Ruíz; Guadalupe Salas-Martínez; Jazmín Ramos-Madrigal; Elaheh Mirzaeicheshmeh; Yolanda Saldaña-Alvarez; María Del Carmen Abrahantes-Pérez; Francisco Loeza-Becerra; Raúl Mojica-Espinosa; Federico Sánchez-Quinto; Héctor Rangel-Villalobos; Martha Sosa-Macías; José Sánchez-Corona; Augusto Rojas-Martinez; Angélica Martínez-Hernández; Lorena Orozco
Journal:  Nat Commun       Date:  2021-10-12       Impact factor: 17.694

5.  Investigating COVID-19 transmission and mortality differences between indigenous and non-indigenous populations in Mexico.

Authors:  Sushma Dahal; Svenn-Erik Mamelund; Ruiyan Luo; Lisa Sattenspiel; Shannon Self-Brown; Gerardo Chowell
Journal:  Int J Infect Dis       Date:  2022-07-26       Impact factor: 12.074

Review 6.  Critical review of social, environmental and health risk factors in the Mexican indigenous population and their capacity to respond to the COVID-19.

Authors:  Lorena Díaz de León-Martínez; Luz de la Sierra-de la Vega; Andrés Palacios-Ramírez; Maribel Rodriguez-Aguilar; Rogelio Flores-Ramírez
Journal:  Sci Total Environ       Date:  2020-05-12       Impact factor: 7.963

7.  Ethnic disparities in COVID-19 mortality in Mexico: A cross-sectional study based on national data.

Authors:  Ismael Ibarra-Nava; Kathia G Flores-Rodriguez; Violeta Ruiz-Herrera; Hilda C Ochoa-Bayona; Alfonso Salinas-Zertuche; Magaly Padilla-Orozco; Raul G Salazar-Montalvo
Journal:  PLoS One       Date:  2021-03-10       Impact factor: 3.240

Review 8.  Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention.

Authors:  Alejandra Rocío Pérez-Martín; Denisse Castro-Eguiluz; Lucely Cetina-Pérez; Yadira Velasco-Torres; Antonio Bahena-González; Edgar Montes-Servín; Ernesto González-Ibarra; Raquel Espinosa-Romero; Dolores Gallardo-Rincón
Journal:  Bosn J Basic Med Sci       Date:  2022-07-29       Impact factor: 3.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.